TranScrip Partners Announce US Expansion
* Reuters is not responsible for the content in this press release.
http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130405:nBw055265a TranScrip Partners, the cutting edge contract organisation, announces opening of US office to better service global client base PHILADEPHIA--(Business Wire)-- TranScrip Partners, the rapidly growing, cutting-edge contract organisation today announced the formation of its US office, TranScrip Partners (USA) LLC. The US branch of TranScrip Partners will be led by Glenn Tillotson, a pharmaceutical expert with 25 years` industry experience and a successful track record in drug development and life cycle management. The expansion of EU-based TranScrip Partners to the US follows the opening of offices in Australia late last year. The launch of the US office marks an important milestone in the expansion of TranScrip Partners. "Establishing TranScrip`s presence in the US will allow us to better support our clients and their global drug development programmes and will add to the depth and breadth of our expertise in drug development and commercialisation", said TranScrip`s Managing Partner Dr Flic Gabbay. http://mms.businesswire.com/bwapps/mediaserver/ViewMedia?mgid=364203&vid=4 Glenn Tillotson, Senior Partner, US Office Lead, TranScrip Partners (Photo: Business Wire) TranScrip Partners supports biopharmaceutical product development and life-cycle management across a client base of over 80 companies. TranScrip Partners challenges the traditional CRO model by offering to clients both top-level therapeutic expertise in overcoming the hurdles encountered from translational medicine to successful registration and market access and the staff to support the projects. Services offered by TranScrip Partners include development and market positioning strategies for early molecules as well as tailored support in drug development, medical affairs, pharmacovigilance, regulatory and medical writing during pre and post-approval. The unique "one-stop shop", character of its organisational model, offers an innovative solution to managing the ever increasing costs of fixed overheads in Pharmaceutical R&D. TranScrip Partners is a rapidly growing cutting-edge contract organisation that supports biopharmaceutical product development and life cycle management. TranScrip Partners are strategic thinkers that do, and doers who think strategically. Working for more than 80 companies across four continents, TranScrip challenges the traditional CRO model by championing medicinal products and overcoming the hurdles encountered from translational medicine to successful registration and market access. Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130405005265/en/ USA: Glenn S Tillotson PhD TranScrip Partners (USA) LLC Tel: 610 383 5705 office Cell: 858 361 3613 Email: firstname.lastname@example.org or UK Headquarters: Leona Brunt TranScrip Partners LLP Tel: +44 1189 637846 Fax: +44 1189 637497 Email: email@example.com Web: www.transcrip-partners.com Twitter: @TranScripPtnr Copyright Business Wire 2013
- Housing, jobs data weaken, but overall economic picture still upbeat
- Target cyber breach hits 40 million payment cards at holiday peak |
- UPDATE 3-Saab wins Brazil jet deal after NSA spying sours Boeing bid
- 'Duck Dynasty' anti-gay fallout sparks debate on religion, tolerance
- Zuckerberg to sell Facebook shares worth about $2.3 billion |